CSIMarket Company Name, Ticker, Competitors, else..
 
Ngm Biopharmaceuticals Inc   (NASDAQ: NGM)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 83
 Employees 100
 Revenues (TTM) (Millions $) 4
 Net Income (TTM) (Millions $) -142
 Cash Flow (TTM) (Millions $) -16
 Capital Exp. (TTM) (Millions $) 1

Business Description


NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company that focuses on developing transformative therapeutics for serious diseases. The company utilizes its expertise in biology, chemistry, and immunology to discover and develop novel therapies.

NGM Biopharmaceuticals is known for its innovative approach to drug discovery, using cutting-edge technology and advanced research techniques to identify targets and potential therapeutic candidates. The company's pipeline includes therapies for several indications, including liver diseases, ophthalmology, and cancer.

NGM Biopharmaceuticals has a strong commitment to improving patient outcomes and addressing unmet medical needs. The company's mission is to develop safe and effective therapies that make a meaningful impact on patients' lives.

Overall, NGM Biopharmaceuticals Inc is a dynamic biopharmaceutical company with a robust pipeline and a focus on innovative drug discovery to address critical diseases.


   Company Address: 333 Oyster Point Boulevard South San Francisco 94080 CA
   Company Phone Number: 243-5555   Stock Exchange / Ticker: NASDAQ NGM


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV   -1.43%    
AZN   -3.17%    
GSK   -5.38%    
NVS   -15.67%    
PFE   -4.46%    
SNY   -3.94%    
• View Complete Report
   



Stock Market Announcement

NGM Bio Announces Successful Completion of Cash Tender Offer, Paving the Way for Transformative Therapeutics

Published Fri, Apr 5 2024 1:20 PM UTC

SAN FRANCISCO, April 5, 2024 - NGM Biopharmaceuticals, Inc. (NGM Bio), a pioneering biotechnology company focused on developing innovative therapeutics for patients, made a significant announcement today. The company revealed that Atlas Neon Parent, Inc. (Parent), an affiliate of The Column Group, LP (TCG), has successfully completed a cash tender offer to acquire all outsta...
Merger and Acquisition

NGM Bio Joins Forces with Affiliates of The Column Group, LP to Redefine Biotechnology

Published Mon, Feb 26 2024 2:04 PM UTC

NGM Bio s Merger Agreement: Revolutionizing Biotechnology with The Column Group
SAN FRANCISCO, Feb. 26, 2024 - NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a groundbreaking biotechnology company renowned for its transformative therapeutics, has recently announced a game-changing move in the industry. NGM Bio has entered into a definitive Agreement and Plan of Me...
Clinical Study

NGM Bio's Promising Clinical Data for NGM707 and Strategic Focus on Rare Conditions with Unmet Need

Published Tue, Jan 9 2024 1:00 PM UTC

NGM Biopharmaceuticals, Inc. (NGM Bio), a prominent biotechnology company dedicated to revolutionizing therapeutic options for patients, recently shared promising clinical findings from an ongoing Phase 1 Part 1b study involving NGM707, a remarkable dual ILT2/ILT4 antagonist antibody candidate. Furthermore, NGM Bio presented its strategic plan to refocus the clinical develop...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 7.18
Working Capital Ratio 7.79
Leverage Ratio (MRQ) 0.14
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.73 $
Revenues (TTM) 0.05 $
Cash Flow (TTM) -
Cash 1.75 $
Book Value 1.8 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 44,170
Net Income per Employee (TTM) -1,423,750
Receivable Turnover Ratio (TTM) 8.61
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.02

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -17977.58 %
Net Margin (MRQ) -16769.7 %
Net Cash Flow Margin (MRQ) 2630.3 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.